drugset / Trial / NCT06722820
Study to Evaluate LPH-5 in Healthy Subjects
RandomizedSequentialDouble-blindTreatment
Summary
This study will explore the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of LPH-5.
Timeline
- Start
- 2025-04-30
- Primary completion
- 2025-11-30
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LPH-5 | Unknown | — | — |
Indications
No indication recorded.